{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:15318"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:15318","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Regulation of CD4\\(^+\\) T cell Il10 transcription and TCR signal strength in tolerance and cancer","abstract":"T cells secrete IFNγ, which has a key role in activating macrophages and enhancing antigen presentation through increasing MHC class I and II expression. The inflammatory response is counteracted by negative regulators of the immune system, which limit damage to self by excessive immune responses, including via FOXP3\\(^+\\) CD4\\(^+\\) Tregs and Type 1 Regulatory CD4\\(^+\\) T cells (Tr1 cells). These induce negative regulation through PD-1, CTLA-4 and TIGIT, for example, but also through expression of immunosuppressive cytokines such as interleukin-10. Previously published data showed that immunisation with modified myelin basic protein ([4Y]-MBP) peptide to transgenic Tg4 T cell Receptor (TCR) mice that specifically and uniquely recognise MBP led to rapid induction of \\(Il10\\) transcription in a CD4\\(^+\\) T cell subset. Here we sought to define and modulate \\(Il10^+\\) T cell early development. We found that a high dose of [4Y]-MBP peptide rapidly induced a Tr1-like phenotype in \\(Il10\\) expressing CD4\\(^+\\) T cells, and that emergence of Tr1-like cells was preceded by Ifng transcription. Via APCs, anti-IFNγ strongly reduced CD4\\(^+\\) Il10 transcription, strong TCR signalling, and Tr1-like markers, an effect that was additive with anti-IL-27. In complementary experiments, we explored the role of IFNγ in modulating T cell \\(Il10\\) transcription during an anti-tumour immune response. Anti-IFNγ increased tumour burden in mice, reducing their survival, which was associated with reduced CD4\\(^+\\) T cell \\(Il10\\) transcription and TCR signalling strength. Changes in \\(FoxP3^+\\) Treg \\(Il10\\) transcription through IFNγ neutralisation correlated with reduced activation of tumour associated macrophages. These data reveal a regulatory feedback role for IFNγ and TCR signalling strength in modulating Il10 transcription in two distinct subsets of regulatory T cells under a variety of immune environments.","abstract_html":"T cells secrete IFNγ, which has a key role in activating macrophages and enhancing antigen presentation through increasing MHC class I and II expression. The inflammatory response is counteracted by negative regulators of the immune system, which limit damage to self by excessive immune responses, including via FOXP3<span class=\"etd-inline-math\"><sup>+</sup></span> CD4<span class=\"etd-inline-math\"><sup>+</sup></span> Tregs and Type 1 Regulatory CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells (Tr1 cells). These induce negative regulation through PD-1, CTLA-4 and TIGIT, for example, but also through expression of immunosuppressive cytokines such as interleukin-10. Previously published data showed that immunisation with modified myelin basic protein ([4Y]-MBP) peptide to transgenic Tg4 T cell Receptor (TCR) mice that specifically and uniquely recognise MBP led to rapid induction of \\(Il10\\) transcription in a CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cell subset. Here we sought to define and modulate <span class=\"etd-inline-math\">Il10<sup>+</sup></span> T cell early development. We found that a high dose of [4Y]-MBP peptide rapidly induced a Tr1-like phenotype in \\(Il10\\) expressing CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cells, and that emergence of Tr1-like cells was preceded by Ifng transcription. Via APCs, anti-IFNγ strongly reduced CD4<span class=\"etd-inline-math\"><sup>+</sup></span> Il10 transcription, strong TCR signalling, and Tr1-like markers, an effect that was additive with anti-IL-27. In complementary experiments, we explored the role of IFNγ in modulating T cell \\(Il10\\) transcription during an anti-tumour immune response. Anti-IFNγ increased tumour burden in mice, reducing their survival, which was associated with reduced CD4<span class=\"etd-inline-math\"><sup>+</sup></span> T cell \\(Il10\\) transcription and TCR signalling strength. Changes in <span class=\"etd-inline-math\">FoxP3<sup>+</sup></span> Treg \\(Il10\\) transcription through IFNγ neutralisation correlated with reduced activation of tumour associated macrophages. These data reveal a regulatory feedback role for IFNγ and TCR signalling strength in modulating Il10 transcription in two distinct subsets of regulatory T cells under a variety of immune environments.","abstract_has_math":true,"creators":["Lecky, David Arthur John"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025-07","date_published":"2025-07","updated_at":"2026-11-19T09:32:52Z","subjects":["QR180 Immunology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["Wellcome Trust MIDAS Programme"],"render_values":[{"text":"Wellcome Trust MIDAS Programme","href":null,"code":true}]}],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000293335605"],"render_values":[{"text":"0000-0002-9333-5605","href":"https://orcid.org/0000-0002-9333-5605","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/15318/14/Lecky2025PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A15318","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["wellcome_trust"]},{"key":"dc:creator","label":"Author","values":["Lecky, David Arthur John"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000293335605"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2025-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/15318/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["Wellcome Trust MIDAS Programme"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/15318/14/Lecky2025PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["T cells secrete IFNγ, which has a key role in activating macrophages and enhancing antigen presentation through increasing MHC class I and II expression. The inflammatory response is counteracted by negative regulators of the immune system, which limit damage to self by excessive immune responses, including via FOXP3\\(^+\\) CD4\\(^+\\) Tregs and Type 1 Regulatory CD4\\(^+\\) T cells (Tr1 cells). These induce negative regulation through PD-1, CTLA-4 and TIGIT, for example, but also through expression of immunosuppressive cytokines such as interleukin-10. Previously published data showed that immunisation with modified myelin basic protein ([4Y]-MBP) peptide to transgenic Tg4 T cell Receptor (TCR) mice that specifically and uniquely recognise MBP led to rapid induction of \\(Il10\\) transcription in a CD4\\(^+\\) T cell subset. Here we sought to define and modulate \\(Il10^+\\) T cell early development. We found that a high dose of [4Y]-MBP peptide rapidly induced a Tr1-like phenotype in \\(Il10\\) expressing CD4\\(^+\\) T cells, and that emergence of Tr1-like cells was preceded by Ifng transcription. Via APCs, anti-IFNγ strongly reduced CD4\\(^+\\) Il10 transcription, strong TCR signalling, and Tr1-like markers, an effect that was additive with anti-IL-27. In complementary experiments, we explored the role of IFNγ in modulating T cell \\(Il10\\) transcription during an anti-tumour immune response. Anti-IFNγ increased tumour burden in mice, reducing their survival, which was associated with reduced CD4\\(^+\\) T cell \\(Il10\\) transcription and TCR signalling strength. Changes in \\(FoxP3^+\\) Treg \\(Il10\\) transcription through IFNγ neutralisation correlated with reduced activation of tumour associated macrophages. These data reveal a regulatory feedback role for IFNγ and TCR signalling strength in modulating Il10 transcription in two distinct subsets of regulatory T cells under a variety of immune environments."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Regulation of CD4\\(^+\\) T cell Il10 transcription and TCR signal strength in tolerance and cancer"]}]}],"canonical_facts":{"dc:contributor.sponsor":["wellcome_trust"],"dc:creator":["Lecky, David Arthur John"],"dc:date":["2025-07-14"],"dc:date.issued":["2025-07"],"dc:description.abstract":["T cells secrete IFNγ, which has a key role in activating macrophages and enhancing antigen presentation through increasing MHC class I and II expression. The inflammatory response is counteracted by negative regulators of the immune system, which limit damage to self by excessive immune responses, including via FOXP3\\(^+\\) CD4\\(^+\\) Tregs and Type 1 Regulatory CD4\\(^+\\) T cells (Tr1 cells). These induce negative regulation through PD-1, CTLA-4 and TIGIT, for example, but also through expression of immunosuppressive cytokines such as interleukin-10. Previously published data showed that immunisation with modified myelin basic protein ([4Y]-MBP) peptide to transgenic Tg4 T cell Receptor (TCR) mice that specifically and uniquely recognise MBP led to rapid induction of \\(Il10\\) transcription in a CD4\\(^+\\) T cell subset. Here we sought to define and modulate \\(Il10^+\\) T cell early development. We found that a high dose of [4Y]-MBP peptide rapidly induced a Tr1-like phenotype in \\(Il10\\) expressing CD4\\(^+\\) T cells, and that emergence of Tr1-like cells was preceded by Ifng transcription. Via APCs, anti-IFNγ strongly reduced CD4\\(^+\\) Il10 transcription, strong TCR signalling, and Tr1-like markers, an effect that was additive with anti-IL-27. In complementary experiments, we explored the role of IFNγ in modulating T cell \\(Il10\\) transcription during an anti-tumour immune response. Anti-IFNγ increased tumour burden in mice, reducing their survival, which was associated with reduced CD4\\(^+\\) T cell \\(Il10\\) transcription and TCR signalling strength. Changes in \\(FoxP3^+\\) Treg \\(Il10\\) transcription through IFNγ neutralisation correlated with reduced activation of tumour associated macrophages. These data reveal a regulatory feedback role for IFNγ and TCR signalling strength in modulating Il10 transcription in two distinct subsets of regulatory T cells under a variety of immune environments."],"dc:format":["text"],"dc:identifier.grantnumber":["Wellcome Trust MIDAS Programme"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/15318/14/Lecky2025PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/15318/"],"dc:subject":["QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["Regulation of CD4\\(^+\\) T cell Il10 transcription and TCR signal strength in tolerance and cancer"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000293335605"]},"updated_at":"2026-11-19T09:32:52Z"}